Exodus Point Capital Management, LP V Tv Therapeutics Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.51 - $1.0 $11,271 - $22,100	-22,100 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.95 - $1.69 $7,790 - $13,858	8,200 Added 58.99%	22,100 $22,000
Q3 2021 Nov 15, 2021	BUY	$1.53 - $2.22 $21,267 - $30,858	13,900 New	13,900 $21,000
Q1 2020 May 15, 2020	SELL	$1.63 - $3.75 $26,197 - $60,270	-16,072 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.37 - $1.97 $22,018 - $31,661	16,072 New	16,072 $27,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.47B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.